GIS:FRA
Gilead Sciences, Inc
134,00 €
arrow_downward
-1,15%(-1,56) 1D
13 հոկ, 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
134,00 €
High
134,00 €
Low
134,00 €
Mkt. cap
183,41 մլրդ
Avg. vol.
386,00
Volume
0,00
52-wk high
134,58 €
52-wk low
97,79 €
No. of employees
17 հզր
Open
134,00 €
High
134,00 €
Low
134,00 €
Mkt. cap
183,41 մլրդ
Avg. vol.
386,00
Volume
0,00
52-wk high
134,58 €
52-wk low
97,79 €
No. of employees
17 հզր
News stories
From web sources and news partners
Benzinga
·
4 ժամ առաջ
$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
MarketBeat
·
14 ժամ առաջ
Erste Group Bank Comments on Gilead Sciences FY2027 Earnings
ad-hoc-news.de
·
21 ժամ առաջ
Gilead Sciences stock loses 0.04 percent pre-market to EUR 134.45
Yahoo Finance
·
1 օր առաջ
Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEODaniel O'Day
Employees17 հզր
Founded22 հնս, 1987 թ.
HeadquartersFoster City, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitegilead.com